Fetching results...
0 items found

A0949: Gut microbiota signatures are associated with prostate cancer risk

Dr. P.J. (Peter) Boström
Kalinen S.1, Kallonen T.2, Gunell M.2, Ettala O.3, Jambor I.4, Knaapila J.3, Syvänen K.T.3, Taimen P.5, Poutanen M.6, Ohlsson C.7, Aronen H.J.4, Ollila H.8, Pietilä S.9, Elo L.L.9, Lamminen T.3, Hakanen A.J.2, Munukka E.10, Boström P.J.3, Multi-IMPROD Study group11
1University of Turku, Research Center of Infections and Immunity, Turku, Finland, 2Turku University Hospital, Dept. of Clinical Microbiology, Turku, Finland, 3Turku University Hospital, Dept. of Urology, Turku, Finland, 4Turku University Hospital, Dept. of Radiology, Turku, Finland, 5Turku University Hospital, Dept. of Pathology, Turku, Finland, 6University of Turku, Centre for Integrative Physiology and Pharmacology, Turku, Finland, 7University of Gothenburg, Dept. of Internal Medicine and Clinical Nutrition, Gothenburg, Sweden, 8Turku University Hospital, Turku Clinical Research Centre, Turku, Finland, 9University of Turku, Turku Centre for Biotechnology, Turku, Finland, 10University of Turku, Microbiome Biobank, Turku, Finland, 11Helsinki, Tampere, Turku, Pori, Finland
37th Annual EAU Congress
Date – Time - Location
04 July 2022, 10:30 - 12:00, Green Area, Room 3
Abstract Session 50 - Liquid and tumour biomarkers in prostate cancer
Prostate Cancer, localised - Basic Research & Trials, Novel biomarkers
  • © 2022 European Association of Urology
  • Disclaimer